← Human Trials & Peer-Reviewed Studies
Cross-sectional associations of vitamin D status with asthma prevalence, exacerbations, and control in New Zealand adults.
Plain-language guide to PMID 30508643 (2019): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 5110 participants.
Key Facts
- PMID
- 30508643
- Journal
- The Journal of steroid biochemistry and molecular biology
- Year
- 2019
- Study type
- Randomized Controlled Trial
- Authors
- Win SS et al. (8 authors)
- DOI
- 10.1016/j.jsbmb.2018.11.016
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
Previous studies, mostly with children, have reported inconsistent findings on the associations of vitamin D status with asthma prevalence, exacerbations, and control.
Who Took Part
The abstract describes 5110 participants taking part.
By PubMed's age tags, the people studied were middle-aged adults, older adults and people over 80, both men and women.
5110 participants, aged 50-84 years, were recruited from the community into a clinical trial of vitamin D supplementation.
The current analysis is based on baseline blood sample collection to measure serum 25-hydroxyvitamin D (25(OH)D), which was deseasonalized for data analyses; and baseline asthma assessment, which included questions on asthma prevalence, urgent medical care for asthma in the previous 12 months, and control of asthma symptoms in the previous 4 weeks.
How the Study Was Run
In design terms this was a randomized study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
What Was Measured
The subject headings attached to it are Ambulatory Care, Asthma, Cross-Sectional Studies, Prevalence, Vitamin D, Vitamin D Deficiency and Vitamins.
The authors tagged it with the keywords 25-Hydroxyvitamin D, Asthma control, Asthma exacerbations and Cross-sectional survey.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 5110 participants.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2019 (The Journal of steroid biochemistry and molecular biology), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.